GC
GMT Capital’s Takeda Pharmaceutical TAK Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-609,195
| Closed | -$8.3M | – | 77 |
|
2021
Q4 | $8.3M | Sell |
609,195
-41,800
| -6% | -$570K | 0.64% | 29 |
|
2021
Q3 | $10.7M | Sell |
650,995
-563,700
| -46% | -$9.23M | 0.94% | 26 |
|
2021
Q2 | $20.4M | Sell |
1,214,695
-1,254,000
| -51% | -$21.1M | 1.53% | 17 |
|
2021
Q1 | $45.1M | Sell |
2,468,695
-402,700
| -14% | -$7.35M | 3.31% | 10 |
|
2020
Q4 | $52.3M | Buy |
2,871,395
+238,100
| +9% | +$4.33M | 3.73% | 8 |
|
2020
Q3 | $47M | Sell |
2,633,295
-728,581
| -22% | -$13M | 3.42% | 8 |
|
2020
Q2 | $60.3M | Sell |
3,361,876
-209,200
| -6% | -$3.75M | 3.39% | 11 |
|
2020
Q1 | $54.2M | Buy |
3,571,076
+225,100
| +7% | +$3.42M | 3.04% | 9 |
|
2019
Q4 | $66M | Buy |
3,345,976
+193,506
| +6% | +$3.82M | 2.55% | 13 |
|
2019
Q3 | $54.2M | Buy |
3,152,470
+1,177,110
| +60% | +$20.2M | 2% | 15 |
|
2019
Q2 | $35M | Buy |
1,975,360
+397,400
| +25% | +$7.03M | 1.22% | 28 |
|
2019
Q1 | $32.1M | Buy |
+1,577,960
| New | +$32.1M | 1.06% | 32 |
|